Bench-to-bedside review: Citrate for continuous renal replacement therapy, from science to practice

To prevent clotting in the extracorporeal circuit during continuous renal replacement therapy (CRRT) anticoagulation is required. Heparin is still the most commonly used anticoagulant. However, heparins increase the risk of bleeding, especially in critically ill patients. Evidence has accumulated th...

Descripción completa

Detalles Bibliográficos
Autores principales: Oudemans-van Straaten, Heleen M, Ostermann, Marlies
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3672558/
https://www.ncbi.nlm.nih.gov/pubmed/23216871
http://dx.doi.org/10.1186/cc11645

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3672558/
https://www.ncbi.nlm.nih.gov/pubmed/23216871
http://dx.doi.org/10.1186/cc11645

Ejemplares similares